<DOC>
	<DOCNO>NCT00995137</DOCNO>
	<brief_summary>This study determine maximum tolerate dose genetically modify natural killer ( NK ) cell research participant relapse refractory B-lineage acute lymphoblastic leukemia ( ALL ) .</brief_summary>
	<brief_title>Genetically Modified Haploidentical Natural Killer Cell Infusions B-Lineage Acute Lymphoblastic Leukemia</brief_title>
	<detailed_description>NK cell cytotoxicity powerful acute myeloid leukemia ( AML ) cell , whereas capacity lyse ALL cell generally low difficult predict . A novel method develop redirect NK cell towards CD19 , molecule highly express surface B-lineage ALL cell , express normal cell B-lymphocytes . In method , donor NK cell first expand co-culture irradiated K562 cell line modify express membrane bound IL-15 41BB ligand ( K562-mb15-41BBL ) . Overexpansion proteins promotes selective growth NK cell . Then , expand NK cell transduce signal receptor bind CD19 ( anti-CD19-BB-zeta ) . NK cell express receptor show powerful anti-leukemic activity CD19+ ALL cell vitro animal model leukemia . This study represent translation laboratory finding clinical application . It allow u assess safety infuse genetically modify NK cell research participant chemotherapy refractory relapse B-lineage ALL . In cohort , also intend study vivo lifespan phenotype genetically modify NK cell explore efficacy NK cell patient B-lineage ALL .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<criteria>Age : le equal 18 year age . May great 18 year age currently St. Jude patient . Patients relapse refractory Blineage ALL eligible hematopoietic stem cell transplantation ( HSCT ) leukemia remission ( &gt; 5 % blast bone marrow evidence either morphology flow cytometry ) . Shortening fraction great equal 25 % . Glomerular filtration rate great equal 50 cc/min/1.73 m2 . Pulse oximetry great equal 92 % room air . Direct bilirubin less equal 3.0 mg/dL . Alanine aminotransferase ( ALT ) 2 time upper limit normal . Aspartate transaminase ( AST ) 2 time upper limit normal . Karnofsky Lansky performance score great equal 50 . No known allergy murine product HAMA test result within normal limit . No prior receipt genetransfer agent ( e.g . retroviral , adenoviral , lentiviral vector ) . Does current pleural pericardial effusion . Has suitable adult family member donor available NK cell donation . Has recover acute NCI Common Toxicity Criteria grade IIIV nonhematologic acute toxicity result previous therapy per judgment principal investigator . At least two week since receipt biological therapy , systemic chemotherapy , and/or radiation therapy . Is receive equivalent prednisone 10 mg daily . Pregnant ( negative serum urine pregnancy test conduct within 7 day prior enrollment ) Breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Relapsed refractory B-Lineage ALL</keyword>
</DOC>